Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 258

1.

Maternal diet during pregnancy and micronuclei frequency in peripheral blood T lymphocytes in mothers and newborns (Rhea cohort, Crete).

O'Callaghan-Gordo C, Kogevinas M, Pedersen M, Fthenou E, Espinosa A, Tsiapa X, Chalkiadaki G, Daraki V, Dermitzaki E, Decordier I, Farmer PB, Georgiadis P, Georgiou V, Kyrtopoulos SA, Merlo DF, Romaguera D, Roumeliotaki T, Sarri K, Törnqvist M, Loock KV, von Stedingk H, Kleinjans J, Kirsch-Volders M, Chatzi L.

Eur J Nutr. 2018 Feb;57(1):209-218. doi: 10.1007/s00394-016-1310-1. Epub 2016 Sep 21.

PMID:
27655526
2.

Antitumour benzothiazoles. Part 32: DNA adducts and double strand breaks correlate with activity; synthesis of 5F203 hydrogels for local delivery.

Stone EL, Citossi F, Singh R, Kaur B, Gaskell M, Farmer PB, Monks A, Hose C, Stevens MF, Leong CO, Stocks M, Kellam B, Marlow M, Bradshaw TD.

Bioorg Med Chem. 2015 Nov 1;23(21):6891-9. doi: 10.1016/j.bmc.2015.09.052. Epub 2015 Oct 3.

PMID:
26474663
3.

Adduct levels from benzo[a]pyrenediol epoxide: Relative formation to histidine in serum albumin and to deoxyguanosine in DNA in vitro and in vivo in mice measured by LC/MS-MS methods.

Westberg EA, Singh R, Hedebrant U, Koukouves G, Souliotis VL, Farmer PB, Segerbäck D, Kyrtopoulos S, Törnqvist MÅ.

Toxicol Lett. 2015 Jan 5;232(1):28-36. doi: 10.1016/j.toxlet.2014.09.019. Epub 2014 Sep 26.

PMID:
25261590
4.

An organizational approach for the assessment of DNA adduct data in risk assessment: case studies for aflatoxin B1, tamoxifen and vinyl chloride.

Pottenger LH, Andrews LS, Bachman AN, Boogaard PJ, Cadet J, Embry MR, Farmer PB, Himmelstein MW, Jarabek AM, Martin EA, Mauthe RJ, Persaud R, Preston RJ, Schoeny R, Skare J, Swenberg JA, Williams GM, Zeiger E, Zhang F, Kim JH.

Crit Rev Toxicol. 2014 Apr;44(4):348-91. doi: 10.3109/10408444.2013.873768. Epub 2014 Feb 4. Review.

PMID:
24494825
5.

Micronuclei in cord blood lymphocytes and associations with biomarkers of exposure to carcinogens and hormonally active factors, gene polymorphisms, and gene expression: the NewGeneris cohort.

Merlo DF, Agramunt S, Anna L, Besselink H, Botsivali M, Brady NJ, Ceppi M, Chatzi L, Chen B, Decordier I, Farmer PB, Fleming S, Fontana V, Försti A, Fthenou E, Gallo F, Georgiadis P, Gmuender H, Godschalk RW, Granum B, Hardie LJ, Hemminki K, Hochstenbach K, Knudsen LE, Kogevinas M, Kovács K, Kyrtopoulos SA, Løvik M, Nielsen JK, Nygaard UC, Pedersen M, Rydberg P, Schoket B, Segerbäck D, Singh R, Sunyer J, Törnqvist M, van Loveren H, van Schooten FJ, Vande Loock K, von Stedingk H, Wright J, Kleinjans JC, Kirsch-Volders M, van Delft JH; NewGeneris Consortium.

Environ Health Perspect. 2014 Feb;122(2):193-200. doi: 10.1289/ehp.1206324. Epub 2013 Nov 19.

6.

Bulky dna adducts in cord blood, maternal fruit-and-vegetable consumption, and birth weight in a European mother-child study (NewGeneris).

Pedersen M, Schoket B, Godschalk RW, Wright J, von Stedingk H, Törnqvist M, Sunyer J, Nielsen JK, Merlo DF, Mendez MA, Meltzer HM, Lukács V, Landström A, Kyrtopoulos SA, Kovács K, Knudsen LE, Haugen M, Hardie LJ, Gützkow KB, Fleming S, Fthenou E, Farmer PB, Espinosa A, Chatzi L, Brunborg G, Brady NJ, Botsivali M, Arab K, Anna L, Alexander J, Agramunt S, Kleinjans JC, Segerbäck D, Kogevinas M.

Environ Health Perspect. 2013 Oct;121(10):1200-6. doi: 10.1289/ehp.1206333. Epub 2013 Jul 23.

7.

Genotoxicity of short single-wall and multi-wall carbon nanotubes in human bronchial epithelial and mesothelial cells in vitro.

Lindberg HK, Falck GC, Singh R, Suhonen S, Järventaus H, Vanhala E, Catalán J, Farmer PB, Savolainen KM, Norppa H.

Toxicology. 2013 Nov 8;313(1):24-37. doi: 10.1016/j.tox.2012.12.008. Epub 2012 Dec 21.

PMID:
23266321
8.

Urinary benzene biomarkers and DNA methylation in Bulgarian petrochemical workers: study findings and comparison of linear and beta regression models.

Seow WJ, Pesatori AC, Dimont E, Farmer PB, Albetti B, Ettinger AS, Bollati V, Bolognesi C, Roggieri P, Panev TI, Georgieva T, Merlo DF, Bertazzi PA, Baccarelli AA.

PLoS One. 2012;7(12):e50471. doi: 10.1371/journal.pone.0050471. Epub 2012 Dec 5.

9.

Human and methodological sources of variability in the measurement of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine.

Barregard L, Møller P, Henriksen T, Mistry V, Koppen G, Rossner P Jr, Sram RJ, Weimann A, Poulsen HE, Nataf R, Andreoli R, Manini P, Marczylo T, Lam P, Evans MD, Kasai H, Kawai K, Li YS, Sakai K, Singh R, Teichert F, Farmer PB, Rozalski R, Gackowski D, Siomek A, Saez GT, Cerda C, Broberg K, Lindh C, Hossain MB, Haghdoost S, Hu CW, Chao MR, Wu KY, Orhan H, Senduran N, Smith RJ, Santella RM, Su Y, Cortez C, Yeh S, Olinski R, Loft S, Cooke MS.

Antioxid Redox Signal. 2013 Jun 20;18(18):2377-91. doi: 10.1089/ars.2012.4714. Epub 2013 Jan 31.

10.

Detection of acetaldehyde derived N(2)-ethyl-2'-deoxyguanosine in human leukocyte DNA following alcohol consumption.

Singh R, Gromadzinska J, Mistry Y, Cordell R, Juren T, Segerbäck D, Farmer PB.

Mutat Res. 2012 Sep 1;737(1-2):8-11. doi: 10.1016/j.mrfmmm.2012.07.001. Epub 2012 Jul 20.

PMID:
22824164
11.

STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement.

Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P; STROBE Statement.

PLoS Med. 2011 Oct;8(10):e1001117. doi: 10.1371/journal.pmed.1001117. Epub 2011 Oct 25. No abstract available.

12.

STrengthening the reporting of OBservational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement.

Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P.

Eur J Epidemiol. 2011 Oct;26(10):797-810. doi: 10.1007/s10654-011-9622-1. Epub 2011 Oct 29. Erratum in: Eur J Epidemiol. 2012 Feb;27(2):151.

PMID:
22037796
13.

STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology STROBE-ME: an extension of the STROBE statement.

Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P.

J Clin Epidemiol. 2011 Dec;64(12):1350-63. doi: 10.1016/j.jclinepi.2011.07.010. Erratum in: J Clin Epidemiol. 2012 Jul;65(7):813.

PMID:
22030070
14.

STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement.

Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P.

Prev Med. 2011 Dec;53(6):377-87. doi: 10.1016/j.ypmed.2011.08.007. Epub 2011 Oct 24. Erratum in: Prev Med. 2012 May;54(5):367.

PMID:
22029945
15.

STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement.

Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P.

Mutagenesis. 2012 Jan;27(1):17-29. doi: 10.1093/mutage/ger039. Epub 2011 Oct 25. Erratum in: Mutagenesis. 2012 May;27(3):383.

PMID:
22027842
16.

STrengthening the Reporting of OBservational studies in Epidemiology: Molecular Epidemiology STROBE-ME. An extension of the STROBE statement.

Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P.

J Epidemiol Community Health. 2012 Sep;66(9):844-54. doi: 10.1136/jech-2011-200318. Epub 2011 Oct 24.

PMID:
22025194
17.

STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement.

Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P.

Eur J Clin Invest. 2012 Jan;42(1):1-16. doi: 10.1111/j.1365-2362.2011.02561.x. Epub 2011 Oct 25. Erratum in: Eur J Clin Invest. 2012 Apr;42(4):462.

18.

Effect of hepatic cytochrome P450 (P450) oxidoreductase deficiency on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-DNA adduct formation in P450 reductase conditional null mice.

Arlt VM, Singh R, Stiborová M, Gamboa da Costa G, Frei E, Evans JD, Farmer PB, Wolf CR, Henderson CJ, Phillips DH.

Drug Metab Dispos. 2011 Dec;39(12):2169-73. doi: 10.1124/dmd.111.041343. Epub 2011 Sep 22.

PMID:
21940903
19.

Evaluation of urinary ribonucleoside profiling for clinical biomarker discovery using constant neutral loss scanning liquid chromatography/tandem mass spectrometry.

Teichert F, Winkler S, Keun HC, Steward WP, Gescher AJ, Farmer PB, Singh R.

Rapid Commun Mass Spectrom. 2011 Jul 30;25(14):2071-82. doi: 10.1002/rcm.5086.

PMID:
21698690
20.

Non-invasive assessment of oxidatively damaged DNA: liquid chromatography-tandem mass spectrometry analysis of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine.

Mistry V, Teichert F, Sandhu JK, Singh R, Evans MD, Farmer PB, Cooke MS.

Methods Mol Biol. 2011;682:279-89. doi: 10.1007/978-1-60327-409-8_20.

PMID:
21057935

Supplemental Content

Loading ...
Support Center